REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea
· Delayed Price · Currency is KRW 11,430
+80 (0.70%)
At close: Apr 25, 2025, 3:30 PM KST
REYON Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 4,151 | 3,583 | 7,434 | 5,537 | 3,844 | Upgrade
|
| Depreciation & Amortization | 6,344 | 4,782 | 4,534 | 4,666 | 4,565 | Upgrade
|
| Loss (Gain) From Sale of Assets | 39.08 | -1.68 | -24.41 | 140.92 | -19.92 | Upgrade
|
| Loss (Gain) From Sale of Investments | -387.54 | 2,453 | -4,262 | -1,125 | -1,573 | Upgrade
|
| Loss (Gain) on Equity Investments | 4,359 | 960.18 | 1,968 | -1,684 | 475.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 24.63 | -63.38 | -79.34 | 467.28 | -1,243 | Upgrade
|
| Other Operating Activities | -17,529 | -439.2 | -1,749 | 1,895 | -409.92 | Upgrade
|
| Change in Accounts Receivable | 3,226 | 1,947 | -1,134 | -986.61 | 4,586 | Upgrade
|
| Change in Inventory | -3,470 | -5,067 | -3,677 | 2,005 | -4,431 | Upgrade
|
| Change in Accounts Payable | 1,807 | 3,394 | 61.52 | 563.61 | 49.39 | Upgrade
|
| Change in Income Taxes | - | -342.94 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.96 | -1,781 | 4,460 | 199.4 | -1,475 | Upgrade
|
| Operating Cash Flow | -1,436 | 8,645 | 8,729 | 11,685 | 4,599 | Upgrade
|
| Operating Cash Flow Growth | - | -0.96% | -25.29% | 154.04% | - | Upgrade
|
| Capital Expenditures | -16,012 | -28,870 | -63,133 | -116,978 | -52,308 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.72 | 42.27 | 8 | 4.37 | Upgrade
|
| Sale (Purchase) of Intangibles | 488.93 | -2.5 | - | -18.7 | 421.46 | Upgrade
|
| Investment in Securities | -1,081 | 19,979 | 10,566 | 2,076 | 22,222 | Upgrade
|
| Other Investing Activities | 13 | 152.12 | -38.93 | 231.1 | 65.5 | Upgrade
|
| Investing Cash Flow | -16,591 | -8,739 | -52,564 | -114,682 | -29,594 | Upgrade
|
| Short-Term Debt Issued | 3,000 | - | - | 3,500 | 7,000 | Upgrade
|
| Long-Term Debt Issued | 85,000 | 13,100 | 113,900 | 150,100 | 32,900 | Upgrade
|
| Total Debt Issued | 88,000 | 13,100 | 113,900 | 153,600 | 39,900 | Upgrade
|
| Long-Term Debt Repaid | -81,121 | -2,205 | -116,104 | -2,475 | -2,678 | Upgrade
|
| Total Debt Repaid | -81,121 | -2,205 | -116,104 | -2,475 | -2,678 | Upgrade
|
| Net Debt Issued (Repaid) | 6,879 | 10,895 | -2,204 | 151,125 | 37,222 | Upgrade
|
| Issuance of Common Stock | - | - | - | 10,000 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -76.31 | - | Upgrade
|
| Dividends Paid | -2,751 | -2,738 | -4,563 | -3,464 | -5,785 | Upgrade
|
| Other Financing Activities | -0 | -3.83 | - | -9.23 | -45.27 | Upgrade
|
| Financing Cash Flow | 4,128 | 8,153 | -6,767 | 157,576 | 31,392 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.21 | -1.28 | -89.04 | -34 | -26.17 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | -0 | -0 | - | Upgrade
|
| Net Cash Flow | -13,898 | 8,058 | -50,691 | 54,544 | 6,371 | Upgrade
|
| Free Cash Flow | -17,448 | -20,225 | -54,404 | -105,293 | -47,708 | Upgrade
|
| Free Cash Flow Margin | -11.77% | -13.39% | -35.32% | -73.73% | -36.69% | Upgrade
|
| Free Cash Flow Per Share | -951.29 | -1102.71 | -2979.96 | -5942.30 | -2801.53 | Upgrade
|
| Cash Interest Paid | 8,478 | 195.52 | 124.02 | 93.37 | 479.43 | Upgrade
|
| Cash Income Tax Paid | 1,315 | 950.65 | 1,188 | -1,488 | 620.58 | Upgrade
|
| Levered Free Cash Flow | 7,306 | -25,600 | -61,372 | -109,157 | -40,494 | Upgrade
|
| Unlevered Free Cash Flow | 8,089 | -25,477 | -61,296 | -109,087 | -40,383 | Upgrade
|
| Change in Net Working Capital | -17,884 | 2,495 | 5,476 | -2,278 | -5,905 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.